No Renal Benefit for mTOR Inhibitors - MedPage Today
MedPage TodayThe mTOR inhibitors everolimus (Zortress, Afinitor) and sirolimus (Rapamune) failed to halt the decline in renal function associated with autosomal dominant
...
read more
